About the Authors

J. Peter Svensson, Rebecca E. E. Esveldt–van Lange, Binie Klein, Harry Vrieling, Micheline Giphart-Gassler
Department of Toxicogenetics, Leiden University Medical Center, Leiden, Netherlands

J. Peter Svensson, Ingela Turesson
Department of Oncology, Radiology, and Clinical Immunology, Academic Hospital, Uppsala, Sweden

Lukas J. A Stalpers, Nicolaas A. P Franken, Jaap Haveman
Department of Radiotherapy/LEXOR Laboratory of Experimental Oncology and Radiobiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Corresponding Author


Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

LJAS, NAPF, JH, HV, and MGG initiated the study. LJAS, NAPF, and JH enrolled patients and collected clinical material. LJAS analyzed clinical data. JPS, REEEvL, and BK did the laboratory experiments. JPS analyzed the gene expression data. HV, LJAS, and MGG supervised the study. JPS, LJAS, NAPF, JH, IT, HV, and MGG contributed to writing the paper.